Conduit Pharmaceuticals has reported a future transaction involving Fry Simon Jeremy, scheduled for 12/18/2024. The announcement provides limited details about the nature and scope of the transaction.Fry Simon Jeremy, whose relationship to the issuer is not specified, is listed as the reporting person with an address in Naples, FL. The lack of information in the Table 1 Non-Derivative Securities section suggests this may not involve a straightforward stock purchase or sale.Investors should note that this is a forward-looking announcement, with the transaction date set nearly a year in the future. Further details or amendments may be forthcoming as the date approaches.

Conduit Pharmaceuticals has reported a future transaction involving Fry Simon Jeremy, scheduled for 12/18/2024. The announcement provides limited details about the nature and scope of the transaction.Fry Simon Jeremy, whose relationship to the issuer is not specified, is listed as the reporting person with an address in Naples, FL. The lack of information in the Table 1 Non-Derivative Securities section suggests this may not involve a straightforward stock purchase or sale.Investors should note that this is a forward-looking announcement, with the transaction date set nearly a year in the future. Further details or amendments may be forthcoming as the date approaches.